{"id":"NCT05273749","sponsor":"Tonix Pharmaceuticals, Inc.","briefTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia","officialTitle":"A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of TNX-102 SL Taken Daily At Bedtime In Patients With Fibromyalgia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-04-06","primaryCompletion":"2023-11-14","completion":"2023-11-14","firstPosted":"2022-03-10","resultsPosted":"2024-12-20","lastUpdate":"2025-01-22"},"enrollment":457,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"TNX-102 SL Tablet, 5.6 mg","otherNames":["Low dose cyclobenzaprine sublingual tablets"]},{"type":"DRUG","name":"Placebo SL Tablet","otherNames":["Placebo sublingual tablets"]}],"arms":[{"label":"TNX-102 SL Tablet, 5.6 mg","type":"EXPERIMENTAL"},{"label":"Placebo SL Tablet","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, randomized, parallel-group, double-blind, placebo-controlled, 14-week study designed to evaluate the efficacy and safety of TNX-102 SL 5.6 mg (2 x 2.8 mg tablets) taken daily at bedtime for the treatment of fibromyalgia.","primaryOutcome":{"measure":"Change From Baseline to the Week 14 Endpoint in the Diary NRS Weekly Average of Daily Self Reported Average Pain Severity Scores.","timeFrame":"Baseline (Day -7 to Day -1), Week 14","effectByArm":[{"arm":"TNX-102 SL Tablet, 5.6 mg","deltaMin":-1.8,"sd":null},{"arm":"Placebo SL Tablet","deltaMin":-1.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":33,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":231},"commonTop":["Hypoaesthesia oral","Product taste abnormal","Paraesthesia oral","Tongue discomfort"]}}